0.00Open0.60Pre Close0 Volume0 Open Interest0.50Strike Price0.00Turnover0.00%IV-9.09%PremiumAug 16, 2024Expiry Date0.71Intrinsic Value100Multiplier-7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.02Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Adaptimmune Therapeutics Stock Discussion
😩. I wish I had more capital. This is about to run hard.
Turnaround proxy after FDA approval.
The treatment or cure of cancer, will be a huge business.
$Adaptimmune Therapeutics (ADAP.US)$
No comment yet